United States · 
What does Montreux Growth Partners invest in?
Montreux Growth Partners invests most often at Series B and Series A (48% of the rounds on record), in sectors such as Mental Health, Digital-health and Health-tech.
Montreux Growth Partners highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series A: 48% of its rounds
- 03
Sole investor in 2 rounds, median $16M
- 04
6 exits from the portfolio
What they do
Montreux invests in high growth, commercial stage companies with category leading products, technologies, and services.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Mental HealthDigital-healthHealth-tech
- Based in
- San Francisco, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first45 appearances
- 2026
1 round
- Jan
- 2015
1 round
- Jul
- 2014
5 rounds
- May
- Apr
- Apr
- Feb
- Feb
- 2013
2 rounds
- Jun
- Feb
- 2012
3 rounds
- Jul
- Apr
- Jan
- 2011
3 rounds
- Nov
- Sept
- Feb
- 2010
4 rounds
- Oct
- Sept
- Jun
- Mar
- 2008
1 round
- Aug
- 2007
6 rounds
- Nov
- Sept
- Aug
- Aug
- May
- Mar
- 2006
2 rounds
- Nov
- Sept
- 2005
4 rounds
- Dec
- Aug
- Jun
- Apr
- 2004
5 rounds
- Aug
- Jul
- Jun
- Jun
- Jan
- 2003
1 round
- Sept
- 2002
3 rounds
- Oct
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
DKDaniel K. TurnerManaging Member of the ManageriFiling they signed
HDHoward D. PalefskyManaging Member of the ManageriFiling they signed
JJJohn J. SavareseManaging Member of the ManageriFiling they signed
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed6 in all
Pivot MedicalBought by Stryker CorporationUndisclosedJan 2014
Somaxon PharmaceuticalsBought by Pernix TherapeuticsUndisclosedMar 2013
SkinMedicaBought by AllerganUndisclosedNov 2012
NovaCardiaBought by Merck & Co.$366MSept 2007
NeurogesXListedUndisclosedFeb 2007
Peninsula PharmaceuticalsBought by Johnson & JohnsonUndisclosedApr 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.